Winston-Salem, NC, United States of America

Richard Payne

This inventor holds 8 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 11 EPO patents. Top assignees: Tengion, Inc., Inregen, Prokidney. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Payne. Retrieved from https://idiyas.com/inventor/richard-payne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 50.0

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 12.2

ph-index = 4

Forward Citations = 54(Granted Patents)

Company Filing History:

Regenmed (Cayman) Ltd.

Years Active: 2011-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12157887 - Bioactive renal cells (2024-12-03),

2. 11066666 - Bioactive renal cells (2021-07-20),

3. 10077442 - Bioactive renal cells (2018-09-18),

4. 9724367 - Injectable formulations for organ augmentation (2017-08-08),

5. 9271824 - Cell scaffold constructs (2016-03-01),

6. 8696760 - Scaffolds for organ reconstruction and augmentation (2014-04-15),

7. 8337485 - Cell-scaffold constructs (2012-12-25),

8. 7918897 - Scaffolds for organ reconstruction and augmentation (2011-04-05),

Title: Top Inventor in Winston-Salem, NC

Introduction: Anthony Atala is a prominent figure in the field of regenerative medicine and tissue engineering. His groundbreaking work has significantly advanced the development of lab-grown organs and tissues.

Latest Patents: Atala holds numerous patents related to tissue engineering, including innovations in 3D bioprinting and organ regeneration techniques.

Career Highlights: He is the director of the Wake Forest Institute for Regenerative Medicine and has published extensively in scientific journals, contributing to the understanding of cellular therapies.

Collaborations: Atala has collaborated with various institutions and companies to further research in regenerative medicine, enhancing the potential for clinical applications.

Conclusion: Anthony Atala's contributions to science and medicine continue to inspire future innovations in the field of regenerative medicine.

Profile summary based on public USPTO records.